K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster
- PMID: 1643642
K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster
Abstract
K-ras oncogene mutation has been shown to be a frequent event in pancreatic ductal adenocarcinomas induced by the carcinogen N-nitroso-bis(2-oxopropyl)amine in the hamster. The present study examines the mutational status of the K-ras oncogene in lesions that precede the appearance of invasive ductal adenocarcinomas. Syrian golden hamsters (80-100 g) received 12 weekly doses of 15 mg/kg N-nitroso-bis(2-oxopropyl)amine and were serially sacrificed at 8, 12, 14, 16, or 24 weeks following the initiation of treatment. Ten microns-thick sections of formalin-fixed paraffin-embedded pancreas were examined for hyperplasia, papillary hyperplasia, carcinoma in situ, and invasive and metastatic ductal carcinoma. Marked lesions of interest were scraped from the slide, subjected to polymerase chain reaction-mediated amplification of the first exon of the K-ras gene, and probed by oligonucleotide-specific hybridization for mutations at codon either 12 or 13. Of 186 samples assayed, K-ras codon 12 mutations were detected in 26% of hyperplasias, 46% of papillary hyperplasias, 76% of carcinoma in situ, 80% of adenocarcinomas, and 43% of lymph node metastases. Codon 12 mutations were exclusively G to A changes at the second position. Codon 13 mutations were only detected in 9 of 168 samples. These results suggest that K-ras activation is an early event in N-nitroso-bis(2-oxopropyl)amine-induced pancreatic carcinogenesis in the hamster.
Similar articles
-
The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.Cancer. 1999 Apr 15;85(8):1703-10. Cancer. 1999. PMID: 10223563
-
High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.Carcinogenesis. 1996 Feb;17(2):303-9. doi: 10.1093/carcin/17.2.303. Carcinogenesis. 1996. PMID: 8625455
-
Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.Cancer Res. 1994 Jul 1;54(13):3568-73. Cancer Res. 1994. PMID: 8012983
-
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.Am J Pathol. 1993 Aug;143(2):545-54. Am J Pathol. 1993. PMID: 8342602 Free PMC article. Review.
-
[Molecular pathways of pancreatic carcinogenesis].Ann Pathol. 2002 Oct;22(5):349-55. Ann Pathol. 2002. PMID: 12483152 Review. French.
Cited by
-
Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.Semin Immunopathol. 2013 Mar;35(2):203-27. doi: 10.1007/s00281-012-0340-x. Epub 2012 Sep 7. Semin Immunopathol. 2013. PMID: 22955327 Review.
-
Characterization of three cloned cell lines from a N-nitrosobis(2-hydroxypropyl)amine-induced transplantable hamster pancreatic ductal adenocarcinoma.Int J Pancreatol. 1994 Oct-Dec;16(2-3):171-7. doi: 10.1007/BF02944328. Int J Pancreatol. 1994. PMID: 7868943
-
Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas.Am J Pathol. 1997 Nov;151(5):1447-54. Am J Pathol. 1997. PMID: 9358771 Free PMC article.
-
Development of gene therapy to target pancreatic cancer.Cancer Sci. 2004 Apr;95(4):283-9. doi: 10.1111/j.1349-7006.2004.tb03204.x. Cancer Sci. 2004. PMID: 15072584 Free PMC article. Review.
-
Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.Pancreas. 2014 Oct;43(7):1073-7. doi: 10.1097/MPA.0000000000000161. Pancreas. 2014. PMID: 24987871 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous